会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Process for obtaining ready for fertilization sexual products from
sexually mature fish
    • 从性成熟鱼获得受精性产品的准备过程
    • US4647552A
    • 1987-03-03
    • US684066
    • 1984-12-20
    • Tamas GulyasAniko HorvathGyorgy KeriKaroly NikolicsBalazs SzokeIstvan Teplan
    • Tamas GulyasAniko HorvathGyorgy KeriKaroly NikolicsBalazs SzokeIstvan Teplan
    • A01K61/00A61K38/00C07K7/06C07K7/23C07K14/575A61K37/24
    • C07K7/23A61K38/00Y10S514/80Y10S930/13
    • The invention relates to a process for obtaining ready-for-fertilization sexual products from sexually mature fish in a period independent of their natural spawning season, in which actual stage of ripening is determined by probing of sexual products [sperm or eggs], fish not yet ripe for ovulation are separated from ripe fish, compounds of hormonal effect are administered to fish, and after the ovulation sexual products are obtained from the fish or from their environment.In the process according to the invention a nonapeptide-C.sub.1-4 -alkyl-amide or a decapeptide amide of the general formula (I),Glp-His-Trp-Ser-Tyr-X.sub.1 -X.sub.2 -X.sub.3 -Pro-X.sub.4 (I)whereinX.sub.1 is a glycyl group or a D-isomer of any natural or synthetic amino acid group,X.sub.2 represents an L-amino acid group having 1 to 4 carbon atoms in the side chain, L-phenyl-alanyl or L-tryptophyl group,X.sub.3 represents an L-amino acid group having a C.sub.1-4 alkyl or C.sub.2-4 alkyl-amide side chain,X.sub.4 is a glycine-amide or a C.sub.1-4 alkyl-amide group,as well as salts or metal-complexes of these compounds are administered to fish in a dose of 0.1 .mu.g to 5 mg, and to fish not yet ripe for ovulation the above quantities are administered in at least 2 but at most 12 portions, wherein the last dose used is at least the same or advantageously at least 1.5 times higher than the previous one.The process according to the invention makes possible the obtaining of ripe sexual products ready for natural or artificial fertilization from any fish species in any period, independently of the natural spawning season of fish.
    • 本发明涉及一种独立于自然产卵季节从性成熟鱼获得即食受精性产品的方法,其中成熟的实际阶段是通过探查性产品[精子或卵],鱼类 成熟的排卵与成熟的鱼分离,激素作用的化合物被施用于鱼,并且在排卵之后,从鱼或其环境获得性产物。 在根据本发明的方法中,通式(I)的Glc-His-Trp-Ser-Tyr-X1-X2-X3-Pro-X4(I)的非肽-C1-4-烷基酰胺或十肽酰胺 )其中X1是任何天然或合成氨基酸基团的甘氨酰基或D-异构体,X2表示侧链中具有1至4个碳原子的L-氨基酸基团,L-苯丙氨酰基或L-色氨酸基团 ,X3表示具有C1-4烷基或C2-4烷基 - 酰胺侧链的L-氨基酸基,X4是甘氨酸 - 酰胺或C1-4烷基 - 酰胺基,以及盐或金属络合物 这些化合物以0.1μg至5mg的剂量施用于鱼,并且为了排卵尚未成熟,上述量以至少2但最多12份施用,其中使用的最后剂量至少相同 或有利地比前一个高至少1.5倍。 根据本发明的方法使得可以在任何时间段内获得准备好从任何鱼类进行天然或人造受精的成熟性产品,而与鱼的天然产卵季节无关。
    • 6. 发明授权
    • Process for increasing the sexual activity of birds and useful domestic
mammals and for preparing spermatozoa suitable to their propagation
    • 增加鸟类和有用的家养哺乳动物的性活动和准备适合其繁殖的精子的过程
    • US4751215A
    • 1988-06-14
    • US852217
    • 1986-04-15
    • Janos SeprodiZsolt VadaszPeter PeczelyIstvan TeplanJudit ErchegyiTibor MurayIstvan Gyorvari
    • Janos SeprodiZsolt VadaszPeter PeczelyIstvan TeplanJudit ErchegyiTibor MurayIstvan Gyorvari
    • A61K38/04A61D19/00A61K38/00A61K38/22A61P15/00C07K7/23A61K37/24
    • C07K7/23A61D19/00A61K38/00Y10S514/80Y10S930/13
    • The invention relates to a process for increasing the sexual activity of birds and useful domestic mammals and for preparing spermatozoa suitable to their propagation. The process of the invention comprises treating sexually mature male birds or useful domestic mammals at least twice and at most four times with 0.1 to 5 .mu.g/kg of body weight of a compound of the general formula (I),Glp-His-Trp-Ser-Tyr-X.sub.1 -Leu-Arg-Pro-X.sub.4 (I)whereinX.sub.1 stands for a glycyl group, a natural or synthetic aminoacid or aminoacid derivative of D configuration, an -Asp-Q group of L configuration, wherein Q is attached to the .alpha.-carbonyl moiety of the aspartyl group and represents a C.sub.1-5 alkylamide, an arylamide, a C.sub.1-4 alkoxy or a benzyloxy group; andX.sub.4 stands for a glycylamide or a C.sub.1-4 alkylamide group,while keeping a pause of at least 30 hours and at most 72 hours between the consecutive treatments.The process of the invention can mainly be used in such large-scale breedings, where artificial insemination is employed but it can be used also for any domestic bird or cought wild-fowl and ornamental bird as well as useful domestic mammal under the conditions of the natural reproduction or artificial insemination.
    • 本发明涉及增加鸟类和有用的家养哺乳动物的性活性以及制备适于其繁殖的精子的方法。 本发明的方法包括用0.1至5μg/ kg体重的通式(I)的化合物,Glp-His-Trp,将性成熟的雄性鸟类或有用的家用哺乳动物处理至少两次,最多四次 -Ser-Tyr-X1-Leu-Arg-Pro-X4(I)其中X1表示甘氨酰基,D构型的天然或合成氨基酸或氨基酸衍生物,L构型的-Asp-Q基团,其中Q为 连接到天冬氨酰基的α-羰基部分,并且表示C1-5烷基酰胺,芳基酰胺,C1-4烷氧基或苄氧基; 并且X 4代表甘氨酰酰胺或C 1-4烷基酰胺基团,同时在连续处理之间保持至少30小时和至多72小时的停顿。 本发明的方法主要用于大规模种植,其中人工授精使用,但也可用于任何家禽或被驯养的野禽和观赏鸟以及有用的国内哺乳动物 自然繁殖或人工授精。
    • 9. 发明授权
    • Compounds for reversing drug resistance
    • 用于逆转耐药性的化合物
    • US06297216B1
    • 2001-10-02
    • US08737255
    • 1997-02-19
    • Balazs SarkadiJanos SeprodiOrsolya CsukaMaria MagocsiImre MezoIstvan PalyiIstvan TeplanZsolt VadaszBorbala Vincze
    • Balazs SarkadiJanos SeprodiOrsolya CsukaMaria MagocsiImre MezoIstvan PalyiIstvan TeplanZsolt VadaszBorbala Vincze
    • A61K3804
    • C07K5/06113A61K38/00C07K5/0215C07K5/0606C07K5/06078C07K5/06086C07K5/06104
    • The invention features novel peptide derivatives called Reversins, and provides for their use in a method of reducing the activity of the multi-drug transporter protein MDR1 in order to overcome multidrug resistance in a mammal. The peptide derivatives are of the formula (I) X1n-X2-X3(X4)n-X5, wherein n is 0 or 1, and each n is the same or different; X1 is BOC, BOC-Asu, Z-Asu, benzyloxycarbonyl, Glu(OBzl)-OBzl, Trp-OMe, Trp-Phe-OMe, Phe-Trp-OMe, Phe-Phe-OtBu, Trp-Trp-OtBu, indoloacetyl, benzoyl, an alkylanine of 1-4 carbons, dibenzylamide, tryptamide, 1-amino-adamantine, aminomethylcyclohexane, indoline, phenylethylamide or dicyclohexylamide; X2 is Glu(OBzl), Asp(OBzl), succinyl, O,O-dibenzoyltartaroyl, diphenoyl, muconyl, Thx, Cpa, Asu, Nal, Pen, Phg, Dbt, Lys(BOC), Lys(Z), Cys(Bzl), Thr(Bzl), Glu(OtBu), tert.-Leu, Leu, Nle, Pro, Phe, Tyr(Bzl), or Ser(Bal); X3 is Asp, Asu, Lys, Glu, Trp, Thx, Cpa, Nal, Pen, Phg, Dbt, Glu(OtBu), tert.-Leu, Leu, Nle, Pro, Tyr, Phe, or Tyr(Bzl); X4 is BOC-Glu(OBzl), Glu(OBzl), Asu, OBzl, Bzl, BOC, BOC-Lys(BOC), Z-Glu(OtBu), Asp(OBzl), Asp(OBz)-OBzl, benzyloxycarbonyl, O-(cyclo-hexyl), fluorenylmethyl ester, Glu(OtBu), Glu(OtBu)-OBzl, 1-amino-adamantine, aminomethylcyclohexane, indoline, phenylethylarnide, or dicyclohexylamide; and X5 is OMe, OBzl, OtBu, Phe-OMe, -O-(cyclohexyl), Trp-OMe, (chlorophenyl)-isobutylamide, fluorenylmethyl ester, ONp, 1-aminoadamantane, aminomethylcyclohexane, indoline, phenylethylamide, or dicyclohexylamide.
    • 本发明的特征在于新颖的肽衍生物,称为Reversins,并且它们用于降低多药物转运蛋白MDR1活性的方法,以克服哺乳动物的多药耐药性。 肽衍生物具有式(I)X1n-X2-X3(X4)n-X5,其中n为0或1,并且各个n相同或不同; X1是BOC,BOC-Asu,Z-Asu,苄氧基羰基,Glu(OBzl)-OBz1,Trp-OMe,Trp-Phe-OMe,Phe-Trp-OMe,Phe-Phe-OtBu,Trp-Trp-OtBu,吲哚乙酰 ,苯甲酰基,1-4个碳的烷基烷基,二苄酰胺,胰蛋白酶,1-氨基 - 金刚烷,氨基甲基环己烷,二氢吲哚,苯乙酰胺或二环己基酰胺; X2是Glu(OBzl),Asp(OBzl),琥珀酰基,O,O-二苯甲酰基联苯酰基,二苯甲酰基,粘蛋白,Thx,Cpa,Asu,Nal,Pen,Phg,Dbt,Lys(BOC),Lys(Z) Bzl),Thr(Bzl),Glu(OtBu),叔-Leu,Leu,Nle,Pro,Phe,Tyr(Bzl)或Ser(Bal) X3是Asp,Asu,Lys,Glu,Trp,Thx,Cpa,Nal,Pen,Phg,Dbt,Glu(OtBu),叔-Leu,Leu,Nle,Pro,Tyr,Phe或Tyr(Bzl); X4是BOC-Glu(OBzl),Glu(OBz1),Asu,OBz1,Bzl,BOC,BOC-Lys(BOC),Z-Glu(OtBu),Asp(OBzl),Asp(OBz) O-(环己基),芴基甲基酯,Glu(OtBu),Glu(OtBu)-OBzl,1-氨基 - 金刚烷,氨基甲基环己烷,二氢吲哚,苯乙基胺或二环己基酰胺; 和X5是OMe,OBz1,OtBu,Phe-OMe,-O-(环己基),Trp-OMe,(氯苯基) - 异丁基酰胺,芴甲基酯,ONp,1-氨基金刚烷,氨基甲基环己烷,二氢吲哚,苯乙酰胺或二环己基酰胺。